The health ministry has approved the Pfizer/BioNTech Covid-19 vaccine for domestic emergency use.
Developed in partnership between Germany company BioNTech and US firm Pfizer, this is the fourth vaccine to receive such authorisation, following Oxford/AstraZeneca, Sputnik V, and Sinopharm’s Vero Cell.
According to the approval decision signed by deputy health minister Tran Van Thuan, the product – named Comirnaty – comes in doses of 0.3ml of mRNA molecules protected by lipid nanoparticles.
The packaging is described as trays of 195 vials, with each vial holding six doses of vaccine.
The decision is made based on safety and efficacy data provided by Pfizer Vietnam Co Ltd to the health ministry by May 28, and commitment by the company that the data has been reviewed and approved by the European Medicines Agency.
The company is expected to coordinate with the manufacturer in ensuring the standards of the Comirnaty vaccine, along with the quality of the products imported into Vietnam.
As of Saturday, 1,454,221 doses of vaccines – mostly AstraZeneca – have been administered since the inoculation drive started on March 8. A total of 54,385 people have received the full two doses. — Vietnam News/ANN